RECENT NEWS

Targeting diffuse large B‐cell lymphoma

The Cancer Research Technology (CRT) Pioneer Fund has invested in the development of a promising new class of drugs for blood cancer. The funding will support Cancer Research UK scientists at The Institute of Cancer Research, London, who are designing the drugs, to treat patients with diffuse large B‐cell lymphoma (pictured), a subtype of non‐Hodgkin’s lymphoma.

News

/ Feb 01, 2017

Single-cell RNASeq system accelerates cancer research

Researchers at The Institute of Cancer Research (ICR), London, are taking advantage of the single-cell encapsulation capabilities of Dolomite Bio’s Single Cell RNASeq system to investigate resistance mechanisms in prostate cancer. Karolina Nowakowska, a PhD student at ICR, explained: “Our team is focused on studying treatment resistance in prostate cancer patients, looking at the biochemical mechanisms responsible. My project is based on using single-cell sequencing to help identify the specific genes which lead to treatment resistance, trying to identify biomarkers and, in the longer term, treatments that will allow a more personalised approach to therapy.”

News

/ Feb 01, 2017

Genetic biomarker for glioma

Researchers from the Harold C Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have found that high expression of a gene called SHOX2 predicts poor survival in intermediate grade gliomas. This potential biomarker for glioma, a common type of brain cancer, could help clinicians determine how aggressive a cancer is, and help to determine the best course of treatment.

News

/ Feb 01, 2017

Reshaping ideas of bacterial evolution

The shape of bacteria does not influence how well they can move. This is the surprising finding of new research which could have major implications for the future of the scientific and medical industries. Published in Nature’s new Ecology & Evolution journal, the results refute long-held theories that there should be a strong link between the evolution of shape in bacteria and their ability to move.

News

/ Feb 01, 2017

Expertise in healthcare IT recognised

Beckman Coulter has appointed Ed Harris as its new product manager for IT in Northern Europe. As a product expert with a passion for healthcare and a vision of the benefits that IT can bring to patient outcomes through enhanced efficiencies, Ed is responsible for overseeing Beckman Coulter’s clinical information systems portfolio. He will also drive the company’s IT strategy and product innovation in order to advance healthcare for all stakeholders. In particular, he will ensure the effective support of clinical laboratory managers in their drive for efficiency and quality.

News

/ Dec 14, 2016

Celebrating National Pathology Week

Recently, pathologists and laboratory scientists came together to celebrate another National Pathology Week (NPW), during which they staged events to increase awareness and improve the public understanding of pathology.

News

/ Nov 28, 2016

Legionella testing: temperature and humidity data logging

Test equipment specialist Testo has supplied its Saveris 2 temperature and humidity data logging system to Stansted Laboratories’ facility in Barking, East London. Stansted Laboratories is a UKAS-accredited laboratory of 20 staff analysing over 50,000 samples a year in a purpose built facility. It specialises in microbiological analysis of water and air, and especially Legionella testing of water and drinking water bacteriological analysis.

News

/ Nov 28, 2016

OC-Sensor – The World’s No.1 Faecal Immunochemical Test

Approximately 41,000 people are diagnosed with colorectal cancer (CRC) in the UK each year, and over 90% of cases are treated successfully following early detection. However, to selectively refer those patients with suspected CRC in a primary care setting remains immensely challenging. The recent revision of the National Institute for Health and Care Excellence (NICE) NG12 ‘red flag’ criteria for the two-week wait aims to increase the CRC detection rate.

News

/ Nov 18, 2016

Circulating prostate cancer cells: predicting metastasis

Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. This is the first time that these cell types have been shown to be a promising marker for prostate cancer spread

News

/ Nov 18, 2016

Stem cells: research, regeneration and treatment

Scientists have discovered a new way to replicate the regenerative power of stem cells in the laboratory, which could lead to powerful treatments for injuries and diseases. In a paper published in the journal ACS Nano, Dr Catherine Berry and Professor Matthew Dalby from the University of Glasgow’s Institute of Molecular Cell and Systems Biology, describe how they have been able create and control bundles of bone marrow stem cells that act as the stem cells do in the body. These bundles of cells are capable of healing injuries in laboratory‐grown bone and cartilage models.

News

/ Nov 18, 2016

Funding for Human Brain Project

A flagship project which launched a range of prototype computer platforms to support brain research, including one based at the University of Manchester, has received an €89 million boost from the European Commission. The Human Brain Project, which comprises six new informatics-based platforms across Europe, aims to accelerate scientific understanding of the human brain, make advances in defining and diagnosing brain disorders, and develop new brain-like technologies.

News

/ Nov 04, 2016

Charity’s victory in heart dental health ruling

Pressure from the charity Heart Research UK has helped bring about a change in advice to dentists about giving antibiotics to heart patients undergoing dental treatment. The victory comes after research, funded by the charity and healthcare provider Simplyhealth, showed that there had been an increase in cases of infective endocarditis since the National Institute for Health and Care Excellence (NICE) recommended in 2008 that at-risk heart patients should no longer receive antibiotic cover during dental treatment.

News

/ Nov 04, 2016

New tests for breast cancer drugs

Scientists have discovered a new way to test hundreds of cancer drugs very quickly, which could cut the time it takes to find potential breast cancer treatments, according to a Cancer Research UK-funded study published recently in the journal Cell (Bruna et al. A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds. Cell 2016). The researchers found they could do this by growing human tumour cells in mice before taking the cells out to run further tests using experimental drugs.

News

/ Nov 04, 2016

Celebrating lifesaving stem cell donors and transplants

More than 3600 patients have received potentially lifesaving bone marrow and stem cell transplants during the last 30 years, thanks to the kindness of strangers. NHS Blood and Transplant (NHSBT) is applauding their generous donors on the double anniversary celebration for the British Bone Marrow Registry (BBMR) and the NHS Cord Blood Bank, both of which play an integral part in saving lives.

News

/ Nov 04, 2016

BAC President speaks at Malaysian conference

British Association for Cytopathology President and IBMS Council member Allan Wilson recently travelled to Hong Kong and Malaysia to give talks to students and professionals in the fields of biomedical and laboratory science. Allan is Lead Biomedical Scientist in Cellular Pathology and Advanced Practitioner in Cervical Cytology at Monklands Hospital, Airdrie, and an Honorary Fellow of The Royal College of Pathologists.

News

/ Aug 19, 2016

Over-diagnosis of thyroid cancer

A new report by the International Agency for Research on Cancer (IARC) in collaboration with the Aviano National Cancer Institute in Italy shows that the growing epidemic of thyroid cancer reported in recent decades in several high-income countries is largely due to over-diagnosis (ie the diagnosis of tumours that are very unlikely to cause symptoms or death during a person’s lifetime).

News

/ Aug 19, 2016

Olusegun Olayemi wins Elisabeth Pletscher Award

The International Federation of Biomedical Laboratory Science (IFBLS) has awarded Olusegun Olayemi the Elisabeth Pletscher Award. This award is given to an outstanding IFBLS Associate member for their continuous support of biomedical laboratory science through continuing education and other activities, and to promote the objectives of IFBLS.

News

/ Aug 19, 2016

Life sciences participation at Harvest Festival

In July, life sciences staff at Coventry University were invited to participate in a Science and Nature Trail at the Harvest Festival held at Jimmy’s Farm in Ipswich. Jimmy Doherty, an ex-Coventry University graduate, is well known from the BBC programme Jimmy’s Farm and through his partnership with Jamie Oliver on Channel 4.

News

/ Aug 19, 2016

Taking the fight to antimicrobial resistance

Scientists from around the world attending the EuroScience Open Forum (ESOF) conference in Manchester recently heard that 2016 marks the year a ‘long overdue’ scientific fight back against the threat of antibiotic resistance finally gets underway.

News

/ Aug 12, 2016

Designer protein aids study of Alzheimer’s disease

A new protein which will help scientists to understand why nerve cells die in people with Alzheimer’s disease has been designed in a University of Sussex laboratory.

News

/ Aug 12, 2016

Featured Supplier

The vision of Randox is one of ambition, innovation and commitment to improving health worldwide. We firmly believe that the healthcare of tomorrow depends on the innovations developed today. We are advancing cutting-edge science and technologies that hold the key to groundbreaking improvements in diagnostics and healthcare. Through a heavily...

Learn more »

Latest Issue

Pathology In Practice

Apr 2019

Reducing exposure to antimicrobial agents

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.